Total Payments
$3,325
2024 Payments
$1,040
Companies
16
Transactions
112
Medicare Patients
3,818
Medicare Billing
$284,191
Payment Breakdown by Category
Food & Beverage$2,851 (85.7%)
Education$474.00 (14.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,851 | 106 | 85.7% |
| Education | $474.00 | 6 | 14.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $774.14 | 17 | $0 (2024) |
| Janssen Biotech, Inc. | $590.18 | 19 | $0 (2023) |
| Incyte Corporation | $524.32 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $503.65 | 22 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $225.18 | 2 | $0 (2022) |
| Lilly USA, LLC | $177.63 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $119.90 | 6 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $99.99 | 1 | $0 (2024) |
| LEO Pharma Inc. | $65.11 | 3 | $0 (2024) |
| Verrica Pharmaceuticals Inc. | $56.06 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,040 | 38 | ABBVIE INC. ($326.60) |
| 2023 | $1,006 | 36 | Incyte Corporation ($365.19) |
| 2022 | $817.97 | 28 | ABBVIE INC. ($230.74) |
| 2021 | $461.69 | 10 | AbbVie Inc. ($216.80) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Immunology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.57 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.16 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $134.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: DERMATOLOGY | ||||||
| 09/14/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: DERMATOLOGY | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.88 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.74 | General |
| Category: Immunology | ||||||
| 08/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| Category: Immunology | ||||||
| 08/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.64 | General |
| Category: Immunology | ||||||
| 07/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.24 | General |
| Category: Immunology | ||||||
| 07/12/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Immunology | ||||||
| 07/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.59 | General |
| Category: Immunology | ||||||
| 06/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.53 | General |
| Category: Immunology | ||||||
| 06/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.71 | General |
| Category: Dermatology | ||||||
| 05/24/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: Immunology | ||||||
| 05/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $146.39 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: DERMATOLOGY | ||||||
| 05/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.27 | General |
| Category: Immunology | ||||||
| 05/08/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $21.25 | General |
| Category: DERMATOLOGY | ||||||
| 05/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,085 | 2,368 | $499,220 | $78,915 |
| 2022 | 12 | 1,060 | 2,229 | $418,305 | $80,264 |
| 2021 | 13 | 1,041 | 2,313 | $420,290 | $83,286 |
| 2020 | 9 | 632 | 1,210 | $206,105 | $41,725 |
Total Patients
3,818
Total Services
8,120
Medicare Billing
$284,191
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 266 | 439 | $120,725 | $24,983 | 20.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 157 | 200 | $65,000 | $13,268 | 20.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 216 | 343 | $85,750 | $12,199 | 14.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 102 | 134 | $53,600 | $10,113 | 18.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 159 | 1,052 | $110,845 | $5,335 | 4.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $18,200 | $3,885 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 43 | $15,050 | $3,629 | 24.1% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 14 | 15 | $6,000 | $1,670 | 27.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 40 | $6,000 | $1,322 | 22.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 28 | $9,800 | $1,082 | 11.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,950 | $1,028 | 20.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $3,300 | $400.40 | 12.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 236 | 380 | $104,500 | $22,227 | 21.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 158 | 203 | $65,975 | $13,240 | 20.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 106 | 137 | $54,800 | $11,077 | 20.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 191 | 305 | $76,250 | $10,909 | 14.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 139 | 938 | $32,830 | $4,966 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 42 | $14,700 | $3,583 | 24.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 48 | 48 | $16,800 | $3,251 | 19.4% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 27 | 31 | $12,400 | $3,226 | 26.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 17 | 22 | $8,800 | $2,831 | 32.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 41 | 57 | $19,950 | $2,240 | 11.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 46 | 52 | $7,800 | $1,968 | 25.2% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2022 | 13 | 14 | $3,500 | $746.97 | 21.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 202 | 322 | $85,225 | $18,695 | 21.9% |
About Lauren Trudeau, PA-C
Lauren Trudeau, PA-C is a Physician Assistant healthcare provider based in Quincy, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2020. The National Provider Identifier (NPI) number assigned to this provider is 1851926257.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lauren Trudeau, PA-C has received a total of $3,325 in payments from pharmaceutical and medical device companies, with $1,040 received in 2024. These payments were reported across 112 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,851).
As a Medicare-enrolled provider, Trudeau has provided services to 3,818 Medicare beneficiaries, totaling 8,120 services with total Medicare billing of $284,191. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Quincy, MA
- Active Since 03/05/2020
- Last Updated 04/01/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1851926257
Products in Payments
- TREMFYA (Drug) $737.51
- Sotyktu (Drug) $503.65
- SKYRIZI (Biological) $454.62
- OPZELURA (Drug) $424.33
- HUMIRA (Biological) $297.70
- TALTZ (Drug) $157.48
- SPEVIGO (Drug) $119.90
- DUPIXENT (Biological) $99.99
- REMICADE (Biological) $77.85
- ADBRY (Biological) $65.11
- YCANTH (Drug) $56.06
- EUCRISA (Drug) $50.03
- AMELUZ (Drug) $34.90
- COSENTYX (Drug) $24.71
- RINVOQ (Biological) $21.82
- Otezla (Drug) $20.36
- OLUMIANT (Drug) $20.15
- Bimzelx (Biological) $17.02
- COSENTYX (Biological) $12.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Quincy
David Peckham, Pa-C, PA-C
Physician Assistant — Payments: $41,698
Physician Assistant $41,698
Jessica Bahros, Pac, PAC
Physician Assistant — Payments: $19,452
Physician Assistant $19,452
Jie Chen, P. A, P. A
Physician Assistant — Payments: $15,370
Physician Assistant $15,370
Rebeca Jinga, Pa-C, PA-C
Physician Assistant — Payments: $13,404
Physician Assistant $13,404
Eliana Green, Pa-C, PA-C
Physician Assistant — Payments: $4,497
Physician Assistant $4,497
Miss. Megan Mccrea, Pa-C, PA-C
Physician Assistant — Payments: $3,875
Physician Assistant $3,875